Tag Archives: HIV

Gilead Making a Bundle

Gilead Sciences has once again proven that independent biotechs can innovate with the best of Big Pharma. The Silicon Valley company’s wizardry at weaving multiple drugs into a single weft enabled it to overthrow GlaxoSmithKline as king of HIV in 2007. Yesterday, at the 16th annual Congress of Retroviruses and Opportunistic Infections (CROI), the biotech […]
Posted in Biotech, Emerging Markets, R&D | Also tagged , , | Leave a comment

Clinton Tinkers With Malaria Market

A team of reporters and camera crews packed into the headquarters of the Clinton Foundation on West 125th Street this afternoon to hear the details of former President Bill Clinton’s plan to tinker with the market for malaria drugs “in a way that has positive implications for the pharmaceutical companies,” he said.
Posted in Corporate Responsibility | Also tagged , , , , , , | 4 Comments
  • Categories

  • Meta